Comprised of 39 amino acids, Tirzepatide, a synthetic analog of the gastric inhibitory polypeptide (GIP), stands as a comparatively large peptide that appears to exert physiological potential through targeting and binding to GIP and GLP-1 (glucagon-like peptide-1) receptors. Through this possible binding mechanism, Tirzepatide may stimulate insulin release from pancreatic cells, potentially enhancing glucose metabolism. […] Source
